Develop Health Inc.

Develop Health Inc. , based in the US, specializes in automating the prior authorization process for medications through advanced artificial intelligence, enhancing operational efficiency for healthcare providers and pharmacies. Founded in 2022 and headquartered in Menlo Park, US, Develop Health Inc. focuses on streamlining the medication authorization process.

The company has raised a total of USD 14. 25 mn through its Series A funding round, which was completed on August 20, 2025, led by Wing and included investors Afore Capital, J Ventures, and South Park Commons. The firm has executed a single deal to date. Develop Health specializes in automating the prior authorization process for medication, leveraging advanced artificial intelligence and integration capabilities to enhance efficiency for healthcare providers.

The core offering includes a platform that qualifies medication options, selects the appropriate forms, and manages submission processes directly from Electronic Health Records (EHR) systems, significantly reducing administrative burdens and submission errors. The solution is designed to streamline workflows for prescribers and pharmacies by automating payer follow-ups and providing real-time updates on authorization status, thereby improving patient care outcomes. Current clients include healthcare providers and pharmacy operations across various geographical markets, including the United States, enabling them to navigate the complexities of insurance requirements seamlessly. Develop Health generates revenue primarily through subscription-based services targeted at healthcare providers and pharmacy operations.

Clients engage with the platform under a service agreement that includes varying subscription tiers based on the scale of use and integration complexity. The revenue model is structured around providing access to its comprehensive prior authorization solution, with clients benefiting from increased approval rates and reduced administrative workloads. Each client pays for the service based on the volume of prior authorizations processed and the level of integration with their existing systems, ensuring that clients receive tailored support and ongoing assistance in optimizing their workflows and improving patient care. In August 2025, Develop Health Inc.

raised USD 14. 25 mn in Series A funding led by new investor Wing, with participation from other new investors Afore Capital, J Ventures, and South Park Commons. The company will utilize this funding to expand its operations beyond medication access into the medical benefit space, while also accelerating its initiatives with electronic health records and pharmacy benefit managers.